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Five species of Plasmodium naturally infect humans. Some
species cause non-specific symptoms that can sometimes
progress rapidly to severe and fatal outcomes. Early diag-
nosis and appropriate treatment interrupts progression
and cures disease. Confirmation of diagnosis of malaria
currently relies on microscopy, or on application of rapid
diagnostic tests (RDTs) that are becoming increasingly
widely available and are recommended to confirm infec-
tion before treating it. The diagnosis of malaria by itself is
not sufficient to optimise individual therapies because
there is a growing problem of multidrug resistance in
parasites (particularly Plasmodium falciparum). This limits
the use of some drugs or combinations by severely
compromising their efficacy.
Diagnostic strategies for management of malaria can
therefore be improved in several ways. First by an increase
in sensitivity of detection of parasites that should improve
of the thresholds for detection by the current generation
of RDTs because they cannot identify low parasitaemias.
Second, a diagnostic that can differentiate all the naturally
infecting species of parasite needs to be developed. Finally,
rapid (point-of-care) assessment of the drug resistance sta-
tus of parasites will add greatly to the treatment strategies
available to manage individual patients. Technological
platforms that can deliver information that is currently
missing for the personalised management of malaria infec-
tions are being developed and these advances will be pre-
sented and discussed in the context of the global burden
of disease caused by malaria.
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